vimarsana.com
  1. Home
  2. Live Updates
  3. Phil Nadeau Cowen - Breaking News

Phil Nadeau Cowen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript

VRTX earnings call for the period ending June 30, 2023.

United statesGeoff meachamColin bristowTerence flynnLiisa baykoTerence flynn morgan stanleyDavid risingerSalveen richterStuart arbuckleSalveen richter goldman sachsRobyn karnauskasPhil nadeauSusie lisaMichael yee jefferiesMichael yeePhil nadeau cowen

Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript

VRTX earnings call for the period ending March 31, 2023.

New zealandGeoff meachamPhil nadeauJessica fyeCharlie wagnerReshma kewalramaniJessica fye jpmorganAndrew tsaiAmerica merrill lynchMohit bansalSusie lisaDavid risingerSalveen richterColin bristowTrikafta kaftrioMichael yee

Dynavax Technologies (DVAX) Q4 2022 Earnings Call Transcript

DVAX earnings call for the period ending December 31, 2022.

Ryan spencerMatthew phipps william blairMadhu kumarKelly macdonaldNicole arndtRob janssenRoy buchananDonn casaleMatthew phippsPhil nadeau cowenMadhu kumar goldman sachsDynavax technologiePhil nadeauWilliam blairUs department of defenseGoldman sachs

Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript

VRTX earnings call for the period ending December 31, 2022.

Robyn karnauskasDavid risingerCharlie wagnerReshma kewalramaniEvan seigermanSalveen richter goldman sachsJessica fyeMichael yeePhil nadeau cowenSalveen richterGeoff meachamLiisa baykoAmerica merrill lynchDavid altshulerRobyn karnauskas truistSusie lisa

Vertex Pharmaceuticals (VRTX) Q3 2022 Earnings Call Transcript

VRTX earnings call for the period ending September 30, 2022.

United statesRobyn karnauskasDavid risingerCharlie wagnerReshma kewalramaniEvan seigermanSalveen richter goldman sachsJessica fyeMichael yeePhil nadeau cowenSalveen richterGeoff meachamKripa devarakonda truistSusie lisaColin bristowStuart arbuckle

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.